Mometasone Furoate
Brand name: Mometasone Furoate
Rank #480 of 500 drugs by total cost
$14.7M
Total Cost
266,966
Total Claims
$14.7M
Total Cost
8,842
Prescribers
$55
Cost per Claim
118,010
Beneficiaries
313,377
30-Day Fills
$1,659
Avg Cost/Provider
30
Avg Claims/Provider
About Mometasone Furoate
Mometasone Furoate (sold as Mometasone Furoate) was prescribed 266,966 times by 8,842 Medicare Part D providers in 2023, costing the program $14.7M. At $55 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 477 | Lansoprazole (Lansoprazole) | $15.0M | 309,355 |
| 478 | Raloxifene Hcl (Raloxifene Hcl) | $14.8M | 198,063 |
| 479 | Lanthanum Carbonate (Lanthanum Carbonate) | $14.7M | 13,783 |
| 480 | Mometasone Furoate (Mometasone Furoate) | $14.7M | 266,966 |
| 481 | Lorlatinib (Lorbrena) | $14.7M | 720 |
| 482 | Rasagiline Mesylate (Rasagiline Mesylate) | $14.5M | 47,985 |
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology